ATE528000T1 - Verfahren und zubereitungen zur behandlung des alkoholismus und der alkoholabhängigkeit - Google Patents
Verfahren und zubereitungen zur behandlung des alkoholismus und der alkoholabhängigkeitInfo
- Publication number
- ATE528000T1 ATE528000T1 AT01943689T AT01943689T ATE528000T1 AT E528000 T1 ATE528000 T1 AT E528000T1 AT 01943689 T AT01943689 T AT 01943689T AT 01943689 T AT01943689 T AT 01943689T AT E528000 T1 ATE528000 T1 AT E528000T1
- Authority
- AT
- Austria
- Prior art keywords
- preparations
- methods
- alcohol dependence
- treating alcoholism
- alcoholism
- Prior art date
Links
- 208000007848 Alcoholism Diseases 0.000 title abstract 4
- 201000007930 alcohol dependence Diseases 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0016056A GB0016056D0 (en) | 2000-06-30 | 2000-06-30 | Methods and compositions for the treatment of alcoholism and alcohol dependence |
| GB0017345A GB0017345D0 (en) | 2000-07-15 | 2000-07-15 | Methods and compositions for the treatment of alcoholism and alcohol dependence |
| PCT/GB2001/002930 WO2002002091A2 (en) | 2000-06-30 | 2001-07-02 | Methods and compositions for the treatment of alcoholism and alcohol dependence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE528000T1 true ATE528000T1 (de) | 2011-10-15 |
Family
ID=26244570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01943689T ATE528000T1 (de) | 2000-06-30 | 2001-07-02 | Verfahren und zubereitungen zur behandlung des alkoholismus und der alkoholabhängigkeit |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8003704B2 (de) |
| EP (1) | EP1294377B1 (de) |
| JP (1) | JP2004501963A (de) |
| AT (1) | ATE528000T1 (de) |
| AU (1) | AU2001266223A1 (de) |
| ES (1) | ES2375347T3 (de) |
| WO (1) | WO2002002091A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0326477D0 (en) * | 2003-11-13 | 2003-12-17 | Shs Int Ltd | Medicaments for use in promoting and maintaining abstinence |
| RU2010122970A (ru) * | 2007-11-06 | 2011-12-20 | Си Ви Терапьютикс, Инк. (Us) | Ингибиторы aldh-2 при лечении психиатрических расстройств |
| WO2018071814A1 (en) | 2016-10-14 | 2018-04-19 | The Trustees Of Columbia University In The City Of New York | Methods of treating alcohol abuse disorder |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1172154B (it) | 1981-12-15 | 1987-06-18 | Manetti & Roberts Italo Brit | Piroglutammil-triptofano e suoi derivati,procedimento per la sua preparazione e sue applicazioni terapeutiche |
| US5204369A (en) * | 1991-07-01 | 1993-04-20 | The Endowment For Research In Human Biology | Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse |
| GB9522615D0 (en) * | 1995-11-03 | 1996-01-03 | Pharmacia Spa | 4-Phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity |
| AU3899199A (en) | 1998-05-12 | 1999-11-29 | Endowment for Research in Human Biology, Inc., The | Methods and assays useful in the treatment of alcohol dependence or alcohol abuse |
-
2001
- 2001-07-02 ES ES01943689T patent/ES2375347T3/es not_active Expired - Lifetime
- 2001-07-02 JP JP2002506713A patent/JP2004501963A/ja active Pending
- 2001-07-02 WO PCT/GB2001/002930 patent/WO2002002091A2/en not_active Ceased
- 2001-07-02 EP EP01943689A patent/EP1294377B1/de not_active Expired - Lifetime
- 2001-07-02 AU AU2001266223A patent/AU2001266223A1/en not_active Abandoned
- 2001-07-02 US US10/312,733 patent/US8003704B2/en not_active Expired - Fee Related
- 2001-07-02 AT AT01943689T patent/ATE528000T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1294377A2 (de) | 2003-03-26 |
| EP1294377B1 (de) | 2011-10-12 |
| AU2001266223A1 (en) | 2002-01-14 |
| ES2375347T3 (es) | 2012-02-29 |
| WO2002002091A3 (en) | 2002-05-02 |
| US8003704B2 (en) | 2011-08-23 |
| WO2002002091A2 (en) | 2002-01-10 |
| US20080076796A1 (en) | 2008-03-27 |
| JP2004501963A (ja) | 2004-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20063373L (no) | CD40-antistoff-formuleringer og fremgangsmater | |
| ATE285809T1 (de) | Vorrichtung zur verabreichung einer substanz | |
| NO20030845D0 (no) | Utvalgte fusjonerte pyrrolokarbazoler | |
| EE05382B1 (et) | MandelhappeÁderivaadid,ÁnendeÁvalmistamiseÁmeetod,ÁnendeÁkasutamineÁtrombiiniÁinhibiitoritenaÁjaÁneidÁsisaldavadÁravimkoostised | |
| DE60140072D1 (de) | Vorrichtung zur minimierung der wirkungen eines herzinsults | |
| MY134586A (en) | Novel pyrroles derivatives as pharmaceutical agents | |
| DE50015623D1 (de) | Kovalent verbrückte insulindimere | |
| ATE400573T1 (de) | 1h-imidazochinolinderivate als proteinkinaseinhibitoren | |
| DE60224284D1 (de) | Stabile formulierung von modifiziertem glp-1 | |
| ATE410177T1 (de) | Zusammensetzung und verfahren zur rauchentgiftung | |
| DE60230425D1 (de) | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege | |
| DE60324788D1 (de) | Kombination aus einem nmda-antagonist und acetylcholinesterase-hemmern zur behandlung der alzheimer-krankheit | |
| AP2001002217A0 (en) | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids. | |
| DK1305286T3 (da) | Cyclopentanoindoler, præparater indeholdende sådanne forbindelser og fremgangsmåder til behandling | |
| NZ326555A (en) | Inhibitors of interleukin-1beta converting enzyme (ICE) | |
| ATE326240T2 (de) | Zusammensetzung zur prävention kardiovaskulärer erkrankungen | |
| DE60119896D1 (de) | Verwendung von pramipexol zur behandlung von tabak/nikotin abhängigkeit | |
| ATE260658T1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
| DE60140871D1 (de) | Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase | |
| IS6531A (is) | Aðferðir til að búa til klaríþrómýsín og klaríþrómýsínmilliefni, í megindráttum oxímlaust klaríþrómýsín og lyfjablanda sem inniheldur það | |
| NO20071798L (no) | Dermalt pafore formuleringer for behandling av hudsykdommer i dyr | |
| NO20052494L (no) | Preparater inneholdende melatonin, gingko biloba og biotin. | |
| DE60142037D1 (de) | Nasale verabreichung von metoclopramid zur behandlung der gastroparese | |
| ATE528000T1 (de) | Verfahren und zubereitungen zur behandlung des alkoholismus und der alkoholabhängigkeit | |
| ATE273276T1 (de) | Cyclobutendion-derivate zur behandlung von artherosclerose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |